A b s t r a c t
The term Waldeyer ring is used to encompass the lymphoid tissues of the faucial tonsils, nasopharynx, base of tongue, and oropharynx and, as defined by others, is an extranodal but not an extralymphatic site. 1 Waldeyer ring may be involved by a variety of neoplasms, and carcinomas, most often metastatic from nearby head and neck sites, are most common. Lymphomas involve Waldeyer ring much less often, 2 and most of these tumors are non-Hodgkin lymphomas (NHLs). In published studies, approximately 90% of all lymphomas involving Waldeyer ring are types of NHL, 3 mostly extranodal natural killer/T-cell lymphoma of nasal type and diffuse large B-cell lymphoma, [4] [5] [6] with a lesser number of other types, including extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue, mantle cell lymphoma, and peripheral T-cell lymphoma.
Hodgkin lymphoma (HL) represents approximately 4% of all lymphomas of the head and neck, 7 and most of these neoplasms involve lymph nodes. Extranodal involvement by HL, including Waldeyer ring, is rare. 4, 5 Previous studies of patients with HL have reported a low frequency of involvement of Waldeyer ring. For example, Todd and Michaels 8 reported a frequency of 1% for involvement of the nasopharynx and 1.5% for tonsil and oropharynx. Similarly, Kaplan and colleagues 9 reported that 5 (1.8%) of 285 consecutive patients with HL had involvement of Waldeyer ring. As a result, most previously published series of HL involving Waldeyer ring have been small groups of patients or case reports. In addition, most of the larger and better studies were performed before the advent of immunohistochemical analysis and, therefore, lack confirmatory immunophenotypic data. Most of these studies also used older lymphoma classification systems based on morphologic findings, without ancillary data. A study of a series of cases of HL involving Waldeyer ring, classified according to the currently used World Health Organization (WHO) classification system, has not been published to date.
We describe 22 cases of HL involving Waldeyer ring, including 7 stage I cases, classified according to the WHO classification.
Materials and Methods
We identified 22 cases of HL involving Waldeyer ring in the files of the Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, from January 1973 to December 2004. Eleven cases were treated at this institution and 11 cases were reviewed in consultation. Clinical information was obtained from data submitted at the time of consultation and the medical record. Clinical stage was determined using the Ann-Arbor staging system.
We reviewed H&E-stained tissue sections of each case. We also reviewed all immunostains available, performed at the submitting institution or in our laboratory in the past. Immunohistochemical stains also were performed as part of this study, using fixed, paraffin-embedded tissue sections and an avidin-biotin complex method as previously described. 10, 11 The panel of monoclonal antibodies used included reagents specific for CD15 (Leu M1), CD20 (L-26), CD30 (Ber H2), CD45 (LCA), CD45RO (UCHL-1), Epstein-Barr virus (EBV) latent membrane protein type 1 (LMP-1; CS1-4), and polyclonal CD3. Antibody dilutions varied during the interval of the study. All antibodies were obtained from DAKO, Carpinteria, CA, except CD15, which was purchased from BD Biosciences, San Jose, CA.
All cases were classified using the criteria of the WHO classification system. 12 Although similar to earlier classifications of HL, the lymphocyte-rich classical type of HL now is recognized as an entity in the WHO classification.
Results

Clinical Findings
Clinical data are summarized in ❚Table 1❚. There were 16 males (73%) and 6 females (27%) with a median age of 48 years (range, 5-81 years). Only 1 patient (5%) was a child. Six patients (27%) were at least 60 years old. The disease was localized (stage I) to Waldeyer ring in 7 cases (32%), involved Waldeyer ring and cervical lymph nodes (stage II) in 11 cases (50%), and was associated with abdominal lymphadenopathy and spleen involvement (stage III) in 1 case (5%).
Three patients had a history of NHL, and their disease was not staged. In this subgroup, 1 patient had follicular lymphoma with bone marrow involvement diagnosed in 1989 and was treated with chemotherapy and autologous bone marrow transplantation. The patient experienced a relapse in 1992 with bone marrow involvement by follicular lymphoma but was in clinical remission when HL developed in 1993 with involvement of the mediastinum and liver. Despite chemotherapy, HL involving the bone marrow and then tonsil developed in 1994. Two patients had chronic lymphocytic leukemia/small lymphocytic 
Pathologic and Immunohistochemical Findings
Pathologic and immunohistochemical data are summarized in ❚Table 2❚. According to the WHO classification criteria, all 22 cases were classified as classical HL and 20 cases were further classified as follows: lymphocyte-rich classical ❚Image 1A❚ and ❚Image 1B❚, 8 (36%); nodular sclerosis ❚Image 1C❚, 7 (32%); mixed cellularity, 4 (18%); and lymphocyte depletion, 1 (5%). The remaining 2 cases (9%) arose in patients with CLL/SLL (Image 1E) and therefore were not further classifiable. The 7 stage I cases were classified as follows: lymphocyte-rich classical, 4 (57%); mixed cellularity, nodular sclerosis, and lymphocyte depletion, 1 (14%) each.
In 20 cases, immunohistochemical studies were performed. (These studies were not performed in 2 cases of nodular sclerosis.) In all cases, the Reed-Sternberg and mononuclear variant cells were positive for CD15 and CD30 ❚Image 1D❚. EBV LMP-1 was positive in 12 (67%) of 18 cases assessed, and CD20 was variably positive in 5 (28%) of 18 cases assessed. The neoplastic cells were negative for CD45 (n = 14), CD3 (n = 13), and CD45RO (n = 3) in all cases assessed.
The 12 cases positive for EBV LMP-1 were classified as follows: lymphocyte-rich classical, 4 (33%); mixed cellularity, 3 (25%); nodular sclerosis, 2 (17%); lymphocyte depletion, 1 (8%); and not classified, 2 (17%) ❚Image 1F❚. The patient with lymphocyte depletion HL was HIV+. The clinical stage of the neoplasms in these patients was as follows: I, 4; II, 4; III, 1; and not staged, 3. The 3 patients with unstaged disease had concurrent or a history of NHL.
Discussion
Although HL often involves the head and neck, these neoplasms usually arise in lymph nodes, most frequently in the cervical regions, and extranodal manifestation without nodal involvement is rare. 4, 7 The frequency of HL involving extranodal sites of the head and neck is approximately 4%. 7 Among this group, HL involving Waldeyer ring, which encompasses the lymphoid tissues of the tonsils, nasopharynx, base of the tongue, and oropharynx wall, is even more rare. 3, 6, [13] [14] [15] [16] [17] [18] [19] [20] [21] For the present study, we identified 22 cases of HL involving Waldeyer ring obtained from the files of our institution during a 31-year period.
Although previous studies of HL involving Waldeyer ring can be found in the literature, many of these studies did not include immunohistochemical data. For example, the largest series in the literature, by Cionini et al, 13 --10  LRC  -+  -+  -ND  +  11  MC  -+  +  +  ND  ND  +  12  NS  -+  -+  -ND  -13  LRC  -+  -+  ND  ND  +  14  LD  -+  +  +  -ND  +  15  LRC  -+  -+  ND  ND  ND  16  NS  -+  -+  ND  ND  ND  17  NS  -+  -+  -ND  +  18  LRC  -+  +  +  -ND  -19  LRC  -+  -+  ND  --20  NS  ND  +  -+  --+  21 RS without immunophenotypic workup. Because various types of NHL can resemble HL, such as T-cell/histiocyte-rich large Bcell lymphoma and peripheral T-cell lymphoma, immunohistochemical confirmation is needed to establish the diagnosis of most types of HL, with the possible exception of nodular sclerosis. Another drawback of many previous studies is that older lymphoma classification systems were used. Many of these older classification systems were based purely on morphologic findings and did not incorporate immunohistochemical and other ancillary data. As far as we are aware, this is the first study of a series of HL cases involving Waldeyer ring in which the neoplasms are classified according to the WHO classification. 12 Most reports in the literature suggest that mixed cellularity is the most common type of HL involving Waldeyer ring, 3, [14] [15] [16] [17] [18] although the study by Cionini et al 13 found that lymphocyte predominant HL was most common. Our results are in disagreement with the literature because we had a predominance of the lymphocyte-rich classical (8/22 [36%] ) and nodular sclerosis (7/22 [32%]) types of HL. In addition, more than half of localized (stage I) cases were the lymphocyte-rich classical type. This may be attributable, in large part, to the fact that the category of lymphocyte-rich classical HL was not recognized until it was first proposed as a provisional entity in the Revised European-American Lymphoma classification in 1994. 22 Furthermore, lymphocyte-rich classical HL was refined into nodular and diffuse variants relatively recently, by the European Task Force on Lymphoma project. 23 Many cases classified in the past as mixed cellularity, nodular lymphocyte predominant, or unclassifiable HL might, in retrospect, be better considered the lymphocyte-rich classical type using current terminology and immunohistochemical analysis. 23 Extranodal HL frequently is related to immunodeficiency states, and in affected patients, a variety of anatomic sites can be involved by HL, including Waldeyer ring. 24, 25 Thus, immunodeficiency is one possible explanation for involvement of Waldeyer ring by HL in the 4 patients with a history of lymphoma (n = 3) or HIV infection (n = 1). The HL in all 4 of these patients was positive for EBV, also consistent with immunodeficiency. However, 18 patients in this study had no clinical evidence of immunodeficiency, and 8 (57%) of 14 cases assessed in this apparently immunocompetent group also were positive for EBV. This frequency is higher than the frequency of EBV in most types of HL involving lymph nodes in immunocompetent patients. Previous studies have reported that EBV can be detected in approximately 20% to 60% of classical HL, depending on the histologic type, being lowest in nodular sclerosis and higher in mixed cellularity. 26 Because oropharyngeal epithelium is a lifetime reservoir for EBV and many malignant neoplasms arising at this site are positive for EBV, 2, 3, 14, 17, 18 it seems likely that anatomic location rather than histologic type explains the higher frequency of EBV in HL involving Waldeyer ring. O'Grady and colleagues 27 made a similar suggestion based on the results of their study in which they showed a higher frequency of EBV in localized HL cases involving neck lymph nodes compared with HL cases involving nonneck body sites. Because EBV LMP is known to have oncogenic potential, 28 it seems possible that EBV has a role in pathogenesis rather than simply being a bystander.
In agreement with the literature, in the present study, HL involving Waldeyer ring occurred most often in male patients (16/22 [73%] ) with local symptoms, and 18 (95%) of 19 patients whose disease was staged had stage I or II disease. 3, 14, 16, 20, 21 Three patients had a history of NHL and were not staged; 2 cases in this group were unusual because they had concurrent evidence or a history of CLL/SLL. Thus, these cases can be considered examples of the Hodgkin variant of Richter syndrome. The term Richter syndrome is applied to the development of a secondary aggressive lymphoid malignancy in a patient with a history of CLL/SLL. 29 31 Both cases in the present study were type 2. Richter syndrome has been associated with EBV infection. 32, 33 Although we are not aware of other reported cases of Hodgkin-variant Richter syndrome involving Waldeyer ring, the high frequency of EBV at this anatomic site may contribute to onset of this type of Richter syndrome in these patients.
Hematopathology / ORIGINAL ARTICLE ❚Image 1❚ E, Hodgkin lymphoma associated with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) (Hodgkin-variant Richter syndrome); type II morphologic features with Hodgkin cells in a polymorphous inflammatory background. The small lymphocytes expressed CD20 and CD5, characteristic of CLL/SLL (H&E, ×400). F, The Hodgkin cells in this case were positive for Epstein-Barr virus latent membrane protein-1(×200).
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In summary, HL involving Waldeyer ring is rare; we identified only 22 cases during 31 years. At our institution, the lymphocyte-rich classical and nodular sclerosis types are most common at this anatomic site, with the lymphocyte-rich classical type also predominating (4/7 [57%]) in patients with stage I disease. We suggest that a subset of cases previously described in the literature as mixed cellularity, nodular lymphocyte predominant, and unclassified HL may, in fact, have been cases of lymphocyte-rich classical HL.
